Silence Therapeutics PLC Long-term Investment Intensity
Silence Therapeutics PLC long-term investment intensity. Silence Therapeutics PLC (SLN) has a Long-term Investment Intensity of 0.2% as of September 2024. Long-term investments of $284.00K represent 0.2% of total assets of $169.38 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Silence Therapeutics PLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Silence Therapeutics PLC (2020–2023)
Long-term investment intensity of Silence Therapeutics PLC from 2020 to 2023. This chart shows how Silence Therapeutics PLC's Long-term Investment Intensity has evolved across 4 annual periods from 2020 to 2023. As of September 2024, the intensity stands at 0.2%, reflecting long-term investments of $284.00K against total assets of $169.38 Million USD. See SLN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Silence Therapeutics PLC Long-term Investment Intensity by Year (2020–2023)
Silence Therapeutics PLC long-term investment intensity by year from 2020 to 2023. The table below presents the year-by-year Long-term Investment Intensity for Silence Therapeutics PLC from 2020 to 2023, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Silence Therapeutics PLC assets under control.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.3% | $284.00K | $94.53 Million | ▲ +0.0 pp |
| 2022 | 0.3% | $284.00K | $107.50 Million | ▼ 0.0 pp |
| 2021 | 0.3% | $301.00K | $96.19 Million | ▼ 0.0 pp |
| 2020 | 0.4% | $303.00K | $85.97 Million | — |